Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Double Versus Single Reinitiation Dose of Warfarin After Interruption for Surgery

NCT01348074 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.

NCT NCT01348074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01348074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Double Versus Single Reinitiation Dose of Warfarin After Interruption for Surgery
Lead sponsor
McMaster University
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2011
Completion date
December 31, 2013
Enrollment
104 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, heart valve disease, surgery, venous thromboembolism